EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Technique for Validating Copy Number Variants and Its Application in Familial Exudative Vitreoretinopathy

Li-Li Zhang iD, Zi-Jia Zhao, Kai-Xin Chen, Yu-Qiao Ju, Feng-Juan Gao iD, Yuan Zong iD, Qing Chang iD, Xin Huang iD, Ting Zhang iD, Ge-Zhi Xu iD

Human Mutation · 2026

DOI: 10.1155/humu/9556416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, 2026. Verfasst von Li-Li Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Eye Institute and Department of Ophthalmology, Eye and ENT Hospital, Fudan University, Shanghai, China, fudan.edu.cn. Hauptthemen laut MEDLINE: DNA Copy Number Variations, Retinal Diseases. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inherited diseases have a strong genetic basis, with copy number variants (CNVs) playing a crucial role in their pathogenesis. However, the detection and validation of CNVs remain challenging. In this study, we introduce target enrichment polymerase chain reaction (tecPCR), a novel technique that integrates multiplex polymerase chain reaction (PCR) with next‐generation sequencing (NGS) for enhanced CNV validation, and applied it in familial exudative vitreoretinopathy (FEVR). Using NGS, 97 variants linked to FEVR were identified, including 91 SNVs and 6 CNVs. Of the CNVs, 66.67% (4/6) were validated both by quantitative PCR and tecPCR, yielding a positive predictive value of 100% (95% confidence intervals: 39.8%–100%) and negative predictive value of 100% (95% confidence intervals: 15.8%–100%) for tecPCR in this pilot validation. The validated FEVR genetic test showed a positivity rate of 53.07% (95/179). Moreover, the demographic and ocular features of the FEVR patients with CNVs were comparable to those with SNVs. This study broadens the mutation spectrum of FEVR and demonstrates that tecPCR provides exceptional specificity and sensitivity, making it a promising tool for genetic diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA Copy Number VariationsRetinal DiseasesHumansFemaleFamilial Exudative VitreoretinopathiesHigh-Throughput Nucleotide SequencingMaleMutationMultiplex Polymerase Chain ReactionGenetic TestingChildPolymerase Chain ReactionChild, PreschoolGenetic Predisposition to DiseaseInfantPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

copy number variationfamilial exudative vitreoretinopathynext-generation sequencequantitative PCR analysistarget enrichment

Autor:innen und Institutionen

  • Eye Institute and Department of Ophthalmology, Eye and ENT Hospital, Fudan University, Shanghai, China, fudan.edu.cn.
  • NHC Key Laboratory of Myopia and Related Eye Diseases, Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, China, pumc.edu.cn.
  • Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China, fudan.edu.cn.

ORCID-Profile: Li-Li Zhang, Feng-Juan Gao, Yuan Zong, Qing Chang, Xin Huang, Ting Zhang, Ge-Zhi Xu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, L. L., Zhao, Z. J., Chen, K. X., Ju, Y. Q., Gao, F. J., Zong, Y., Chang, Q., Huang, X., Zhang, T., & Xu, G. Z. (2026). A Novel Technique for Validating Copy Number Variants and Its Application in Familial Exudative Vitreoretinopathy. Human Mutation. https://doi.org/10.1155/humu/9556416

Vancouver

Zhang LL, Zhao ZJ, Chen KX, Ju YQ, Gao FJ, Zong Y, et al. A Novel Technique for Validating Copy Number Variants and Its Application in Familial Exudative Vitreoretinopathy. Human Mutation. 2026. doi:10.1155/humu/9556416

BibTeX
@article{Zhang2026,
  author = {Zhang, Li-Li and Zhao, Zi-Jia and Chen, Kai-Xin and Ju, Yu-Qiao and Gao, Feng-Juan and Zong, Yuan and Chang, Qing and Huang, Xin and Zhang, Ting and Xu, Ge-Zhi},
  title = {A Novel Technique for Validating Copy Number Variants and Its Application in Familial Exudative Vitreoretinopathy},
  journal = {Human Mutation},
  year = {2026},
  doi = {10.1155/humu/9556416}
}
Kostenlos starten →